SCHEMBL21247239

SCHEMBL21247239

CCOC(=O)c1c(N)sc2c1CC[C@H](C)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 1.00
MAPT P10636 11/20 1.00
HPGD P15428 7/20 1.00
KDM4E B2RXH2 7/20 1.00
HSD17B10 Q99714 5/20 1.00
GAA P10253 5/20 1.00
ALOX15 P16050 3/20 1.00
TSHR P16473 1/20 1.00
ALOX12 P18054 1/20 1.00
MAPK1 P28482 1/20 0.65
NPSR1 Q6W5P4 1/20 0.64
SMN1; SMN2 Q16637 2/20 0.61
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
ADORA1 P30542 3/20 0.60
L3MBTL1 Q9Y468 1/20 0.59
POLB P06746 1/20 0.59
HTT P42858 2/20 0.56
NPC1 O15118 1/20 0.56
LMNA P02545 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2949670 1.00 ALDH1A1 (1.00) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL3913632 0.90 ALDH1A1 (0.81) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL14478808 0.86 ALDH1A1 (1.00) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL22402136 0.86 MAPT (0.75) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL5629040 0.85 MAPT (0.73) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL17321001 0.84 MAPT (0.73) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL2944021 0.84 MAPT (0.72) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL18135595 0.84 MAPT (0.74) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL17816395 0.84 MAPT (0.72) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL2306052 0.83 MAPT (0.80) ALDH1A1MAPTHPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11603368-B2 Fused thiophene derivatives and their uses ENYO PHARMA (FR) 2023-03-14 US disclosed
EP-3749658-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO Pharma (FR) 2020-12-16 EP disclosed
US-20200369682-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2020-11-26 US disclosed
WO-2019154949-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2019-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369682-A1 FUSED THIOPHENE DERIVATIVES AND THEIR USES FTH1, SLC40A1, FECH ALDH1A1 2143/4885MAPT 2107/4885HPGD 1515/4885
US-11603368-B2 Fused thiophene derivatives and their uses FTH1, SLC40A1, FECH ALDH1A1 2143/4885MAPT 2107/4885HPGD 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.